SCIENCES

A New Deal for Cancer: Lessons from a 50 Year War

PublicAffairs. Nov. 2021. 416p. ed. by Abbe R. Gluck & Charles S. Fuchs. ISBN 9781541700611. $30. MED
COPY ISBN
the 50th anniversary of Nixon’s signing of the National Cancer Act in 1971 as a springboard, Gluck (Yale Law Sch.) and oncologist Fuchs present 19 essays looking at accomplishments in cancer treatment and the challenges that lie ahead. These essays focus on policy rather than science. An essay by Siddhartha Mukherjee sets the stage by looking at five decades of successes, failures, and newly arisen problems in cancer treatment. Other contributors—in fields like medicine, economics, public health, political science, and patient advocacy—cover a wide range of topics in well-documented detail. Topics include inequity and availability of cancer care, costs, insurance, and caregiving. While viewpoints are varied, there is an overall emphasis on the need to work toward addressing the scattershot nature of pricing and insurance, and the causes of and possible solutions for disparities in care between regions and patients of different demographic groups.
VERDICT The editors have assembled an impressive array of experts, offering a range of views with varying levels of detail. Decision makers in clinical, academic, advocacy, political, and governmental positions will be interested.
Comment Policy:
  • Be respectful, and do not attack the author, people mentioned in the article, or other commenters. Take on the idea, not the messenger.
  • Don't use obscene, profane, or vulgar language.
  • Stay on point. Comments that stray from the topic at hand may be deleted.
  • Comments may be republished in print, online, or other forms of media.
  • If you see something objectionable, please let us know. Once a comment has been flagged, a staff member will investigate.


RELATED 

ALREADY A SUBSCRIBER?

We are currently offering this content for free. Sign up now to activate your personal profile, where you can save articles for future viewing

ALREADY A SUBSCRIBER?